Anders D Hove Receives Stock Award at Arca biopharma Inc (ABIO) — SEC Form 4, Dec 19, 2022

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Anders D Hove

Director

TXN 2022-12-15 · FILED 2022-12-19

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Arca biopharma Inc

ABIO CIK 0000907654

Reporting Owner

Name	Relationship
Anders D Hove CIK 0001365618	Director

Anders D Hove at Arca biopharma Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Arca biopharma Inc

2024-01-31	Award	—	View
2021-01-13	Award	—	View

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F1	$2.32	2022-12-15	A - Award/Grant	6,000 A	$0.00	2032-12-15	6,000 Common Stock	Direct

Footnotes (1)

F1: Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of December 15, 2022. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Arca biopharma Inc

GET /v1/forms/4/0001209191-22-061911 API docs